Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...